Literature DB >> 31180015

Novel DMARD monotherapy in rheumatoid arthritis.

Anna Moltó1, Maxime Dougados2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31180015     DOI： 10.1016/S0140-6736(19)30768-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  N-Butyrylated Hyaluronic Acid Achieves Anti-Inflammatory Effects In Vitro and in Adjuvant-Induced Immune Activation in Rats.

Authors:  Xue Luan; Zhongcheng Cong; Tassos P Anastassiades; Yin Gao
Journal:  Molecules       Date:  2022-05-19       Impact factor: 4.927

2.  Inflammation-Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging-Guided Therapy of Rheumatoid Arthritis.

Authors:  Luoyuan Li; Xuelong Wang; Rongyao Gao; Bei Zhang; Yuxin Liu; Jing Zhou; Limin Fu; Jian Wang
Journal:  Adv Sci (Weinh)       Date:  2022-01-12       Impact factor: 16.806

3.  Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis.

Authors:  Ning Wu; Taohua Yuan; ZhiXin Yin; Xiaotian Yuan; Jianfei Sun; Zunqiu Wu; Qilong Zhang; Carl Redshaw; Shenggang Yang; Xiaotian Dai
Journal:  Drug Des Devel Ther       Date:  2022-02-19       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.